Recombinant equine herpesvirus 1 (EHV-1) vaccine protects pigs against challenge with influenza A(H1N1)pmd09

Virus Research

Volumn 173, Issue 2, 2013, Pages 371-376

  Said, Abdelrahman ^a   Lange, Elke ^b   Beer, Martin ^b   Damiani, Armando ^a   Osterrieder, Nikolaus ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

EHV 1; Pdm09; Vector vaccine

Indexed keywords

HEMAGGLUTININ H1; HERPES VACCINE; RECOMBINANT EQUINE HERPESVIRUS TYPE 1 VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS HEMAGGLUTININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFICACY; EXPERIMENTAL PIG; HUMORAL IMMUNITY; INFLUENZA A (H1N1); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION; VIRAL CLEARANCE; VIRUS IMMUNITY; VIRUS REPLICATION; VIRUS SHEDDING;

ANIMAL EXPERIMENTATION; ANIMALS; ANTIBODIES, VIRAL; GENETIC VECTORS; HERPESVIRUS 1, EQUID; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; SWINE; VACCINES, SYNTHETIC; VIRUS SHEDDING;

AVES; EQUID HERPESVIRUS 1; ORTHOMYXOVIRIDAE; SIMIAN IMMUNODEFICIENCY VIRUS; SUIDAE; SWINE INFLUENZA VIRUS;

EID: 84876873848     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.01.004     Document Type: Article

References (49)

1. Allen G.P., Bryans J.T. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Progress in Veterinary Microbiology and Immunology 1986, 2:78-144.
2. Amorij J.P., Hinrichs W.L.j., Frijlink H.W., Wilschut J.C., Huckriede A. Needle-free influenza vaccination. Lancet Infectious Diseases 2010, 10:699-711.
3. Brave A., Ljungberg K., Wahren B., Liu M.A. Vaccine delivery methods using viral vectors. Molecular Pharmaceutics 2007, 4(1):18-32.
4. Bublot M., Pritchard N., Swayne D.E., Selleck P., Karaca K., Suarez D.L., Audonnet J.C., Mickle T.R. Development and use of fowlpox vectored vaccines for avian influenza. Annals of the New York Academy of Sciences 2006, 1081:193-201.
5. Castrucci M.R., Campitelli L., Ruggieri A., Barigazzi G., Sidoli L., Daniels R., Oxford J.S., Donatelli I. Antigenic and sequence analysis of H3 influenza virus haemagglutinins from pigs in Italy. Journal of General Virology 1994, 75(2):371-379.
6. Couch R.B., Kasel J.A. Immunity to influenza in man. Annual Review of Microbiology 1983, 37:529-549.
7. Davison A.J., Eberle R., Ehlers B., Hayward G.S., McGeoch D.J., Minson A.C., Pellett P.E., Roizman B., Studdert M.J., Thiry E. The order Herpesvirales. Archives of Virology 2009, 154:171-177.
8. Furuse Y., Suzuki A., Oshitani H. Reassortment between swine influenza A viruses increased their adaptation to humans in pandemic H1N1/09. Infection, Genetics and Evolution 2010, 10:569-574.
9. Garten R.J., Davis C.T., Russell C.A., Shu B., Lindstrom S., Balish A., Sessions W.M., Xu X., Skepner E., Deyde V., Okomo-Adhiambo M., Gubareva L., Barnes J., Smith C.B., Emery S.L., Hillman M.J., Rivailler P., Smagala J., de Graaf M., Burke D.F., Fouchier R.A., Pappas C., Alpuche-Aranda C.M., López-Gatell H., Olivera H., López I., Myers C.A., Faix D., Blair P.J., Yu C., Keene K.M., Dotson P.D., Boxrud D., Sambol A.R., Abid S.H., George K., Bannerman T., Moore A.L., Stringer D.J., Blevins P., Demmler-Harrison G.J., Ginsberg M., Kriner P., Waterman S., Smole S., Guevara H.F., Belongia E.A., Clark P.A., Beatrice S.T., Donis R., Katz J., Finelli L., Bridges C.B., Shaw M., Jernigan D.B., Uyeki T.M., Smith D.J., Klimov A.I., Cox N.J. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (New York, NY) 2009, 325(5937):197-201.
10. Girard M.P., Tam J.S., Assossou O.M., Kieny M.P. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine 2010, 28:4895-4902.
11. Hessel A., Schwendinger M., Holzer G.W., Orlinger K.K., Coulibaly S., Savidis-Dacho H., Zips M.L., Crowe B.A., Kreil T.R., Ehrlich H.J., Barrett P.N., Falkner F.G. Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity. PLoS ONE 2011, 6(1):e16247.
12. Hghihghi H.R., Read L.R., Mohammadi H., Pei Y., Ursprung C., Nagy E., Behboudi S., Haeryfar S.M., Sharif S. Characterization of host responses against a recombinant fowlpox virus-vectored vaccine expressing the hemagglutinin antigen of an avian influenza virus. Clinical and Vaccine Immunology 2011, 17(3):454-463.
13. Hübert P.H., Birkenmaier S., Rziha H.J., Osterrieder N. Alterations in the equine herpesvirus type-1 (EHV-1) strain RacH during attenuation. Zentralblatt fur Veterinarmedizin 1996, 43:1-14.
14. Irvine R.M., Brown I.H. Novel H1N1 influenza in people - worldwide spread from an animal source?. Veterinary Record 2009, 164:577-578.
15. Ito T., Couceiro J.N., Kelm S., Baum L.G., Krauss S., Castrucci M.R., Donatelli I., Kida H., Paulson J.C., Webster R.G., Kawaoka Y. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. Journal of Virology 1998, 72(9):7367-7373.
16. Ito T., Couceiro J.N., Kelm S., Baum L.G., Krauss S., Castrucci M.R., Donatelli I., Kida H., Paulson J.C., Webster R.G., Kawaoka Y. Interspecies transmission and receptor recognition of influenza A viruses. Microbiology and Immunology 2000, 44(6):423-430.
17. Kalthoff D., Grund C., Harder T.C., Lange E., Vahlenkamp T.W., Mettenleiter T.C., Beer M. Limited susceptibility of chickens, turkeys, and mice to pandemic (H1N1) 2009 virus. Emerging Infectious Diseases 2010, 16(4):703-705.
18. Kida H., Ito T., Yasuda J., Shimizu Y., Itakura C., Shortridge K.F., Kawaoka Y., Webster R.G. Potential for transmission of avian influenza viruses to pigs. Journal of General Virology 1994, 75(9):2183-2188.
19. Kobinger G.P., Meunier I., Patel A., Pillet S., Gren J., Stebner S., Leung A., Neufeld J.L., Kobasa D., von Messling V. Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus. Journal of Infectious Diseases 2010, 201:1000-1006.
20. Lange E., Kalthoff D., Blohm U., Teifke J.P., Breithaupt A., Maresch C., Starick E., Fereidouni S., Hoffmann B., Mettenleiter T.C., Beer M., Vahlenkamp T.W. Pathogenesis and transmission of the novel swine origin influenza virus A/H1N1 after experimental infection of pigs. Journal of General Virology 2009, 90(9):2119-2123.
21. Larsen D.L., Olsen C.W. Effects of DNA dose, route of vaccination, and coadministration of porcine interleukin-6 DNA on results of DNA vaccination against influenza virus infection in pigs. American Journal of Veterinary Research 2002, 63:653-659.
22. Larsen D.L., Karasin A., Olsen C.W. Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting. Vaccine 2001, 19:2842-2853.
23. Ma W., Richt J.A. Swine influenza vaccines: current status and future perspectives. Animal Health Research Reviews 2010, 11:81-96.
24. Macklin M.D., McCabe D., McGregor M.W., Neumann V., Meyer T., Callan R., Hinshaw V.S., Swain W.F. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. Journal of Virology 1998, 72:1491-1496.
25. Minke J.M., Toulemonde C.E., Coupier H., Guigal P.M., Dinic S., Sindle T., Jessett D., Black L., Bublot M., Pardo M.C., Audonnet J.C. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge. American Journal of Veterinary Research 2007, 68:213-219.
26. Minke J.M., Toulemonde C.E., Dinic S., Cozette V., Cullinane A., Audonnet J.C. Effective priming of foals born to immune dams against influenza by a canarypox-vectored recombinant influenza H3N8 vaccine. Journal of Comparative Pathology 2007, 137(1):S76L S80.
27. Neubauer A., Meindl A., Osterrieder N. Mutations in the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH have no effects on its attenuation. Berliner und Munchener Tierarztliche Wochenschrift 1999, 112:351-354.
28. Osterrieder N., Neubauer A., Brandmuller C., Kaaden O.R., O'Callaghan D.J. The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence. Virology 1996, 226(2):243-251.
29. Palese P., Shaw M.L. Orthomyxoviridae: the viruses and their replication. Fields Virology 2007, 1647-1689. Lippincott Williams & Wilkins, Philadelphia, PA. 5th ed. D.M.K.P.M. Howley (Ed.).
30. Pappaioanou M., Gramer M. Lessons from pandemic H1N1 2009 to improve prevention detection, and response to influenza pandemics from a One Health perspective. ILAR Journal 2010, 51:268-280.
31. Reeth K.V., Brown I., Essen S., Pensaert M. Genetic relationships serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs. Virus Research 2004, 103:115-124.
32. Rosas C., Van de Walle G.R., Metzger S.M., Hoelzer K., Dubovi E.J., Kim S.G., Parrish C.R., Osterrieder N. Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza. Vaccine 2008, 26:2335-2343.
33. Rosas C.T., König P., Beer M., Dubovi E.J., Tischer B.K., Osterrieder N. Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins. Journal of General Virology 2007, 88:748-757.
34. Rosas C.T., Tischer B.K., Perkins G.A., Wagner B., Goodman L.B., Osterrieder N. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV). Virus Research 2007, 125:69-78.
35. Said A., Damiani A., Ma G., Kalthoff D., Beer M., Osterrieder N. An equine herpesvirus 1 (EHV-1) vectored H1 vaccine protects against challenge with swine-origin influenza virus H1N1. Veterinary Microbiology 2011, 154:113-123.
36. Schultz U., Fitch W.M., Ludwig S., Mandler J., Scholtissek C. Evolution of pig influenza viruses. Virology 1991, 183:61-73.
37. Sipo I., Knauf M., Fechner H., Poller W., Planz O., Kurth R., Norley S. Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV). Vaccine 2011, 29(8):1690-1699.
38. Smith G.J., Vijaykrishna D., Bahl J., Lycett S.J., Worobey M., Pybus O.G., Ma S.K., Cheung C.L., Raghwani J., Bhatt S., Peiris J.S., Guan Y., Rambaut A. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009, 459:1122-1125.
39. Tang M., Harp J.A., Wesley R.D. Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2). Archives of Virology 2002, 147(11):2125-2141.
40. Telford E.A., Watson M.S., McBride K., Davison A.J. The DNA sequence of equine herpesvirus-1. Virology 1992, 189:304-316.
41. Tian Z.J., Zhou G.H., Zheng B.L., Qiu H.J., Ni J.Q., Yang H.L., Yin X.N., Hu S.P., Tong G.Z. A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge. Veterinary Immunology and Immunopathology 2006, 111(3-4):211-218.
42. Van Reeth K., Brown I., Essen S., Pensaert M. Avian and swine influenza viruses: our current understanding of the zoonotic risk. Veterinary Research 2007, 38:243-260.
43. Vincent A.L., Ciacci-Zanella J.R., Lorusso A., Gauger P.C., Zanella E.L., Kehrli M.E., Janke B.H., Lager K.M. Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs. Vaccine 2010, 28:2782-2787.
44. Vincent A.L., Lager K.M., Faaberg K.S., Harland M., Zanella E.L., Ciacci-Zanella J.R., Kehrli M.E., Janke B.H., Klimov A. Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera. Influenza and Other Respiratory Viruses 2010, 4(2):53-60.
45. Vincent A.L., Lager K.M., Janke B.H., Gramer M.R., Richt J.A. Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Veterinary Microbiology 2008, 126:310-323.
46. Wang T.T., Palese P. Universal epitopes of influenza virus hemagglutinins?. Nature Structural and Molecular Biology 2009, 16:233-234.
47. Wang T.T., Palese P. Unraveling the mystery of swine influenza virus. Cell 2009, 137:983-985.
48. Webster R.G., Bean W.J. Genetics of influenza virus. Annual Review of Genetics 1978, 12:415-431.
49. Wesley R.D., Tang M., Lager K.M. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 2004, 22(25-26):3427-3434.